These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
328 related articles for article (PubMed ID: 21610264)
1. Validation of a short version of the glaucoma medication self-efficacy questionnaire. Sleath B; Blalock SJ; Stone JL; Skinner AC; Covert D; Muir K; Robin AL Br J Ophthalmol; 2012 Feb; 96(2):258-62. PubMed ID: 21610264 [TBL] [Abstract][Full Text] [Related]
2. The relationship between glaucoma medication adherence, eye drop technique, and visual field defect severity. Sleath B; Blalock S; Covert D; Stone JL; Skinner AC; Muir K; Robin AL Ophthalmology; 2011 Dec; 118(12):2398-402. PubMed ID: 21856009 [TBL] [Abstract][Full Text] [Related]
3. Risk factors for poor adherence to eyedrops in electronically monitored patients with glaucoma. Friedman DS; Okeke CO; Jampel HD; Ying GS; Plyler RJ; Jiang Y; Quigley HA Ophthalmology; 2009 Jun; 116(6):1097-105. PubMed ID: 19376591 [TBL] [Abstract][Full Text] [Related]
5. Evaluating eye drop instillation technique in glaucoma patients. Gupta R; Patil B; Shah BM; Bali SJ; Mishra SK; Dada T J Glaucoma; 2012 Mar; 21(3):189-92. PubMed ID: 21336146 [TBL] [Abstract][Full Text] [Related]
6. Intentional and unintentional nonadherence to ocular hypotensive treatment in patients with glaucoma. Rees G; Leong O; Crowston JG; Lamoureux EL Ophthalmology; 2010 May; 117(5):903-8. PubMed ID: 20153902 [TBL] [Abstract][Full Text] [Related]
7. A video study of drop instillation in both glaucoma and retina patients with visual impairment. Hennessy AL; Katz J; Covert D; Kelly CA; Suan EP; Speicher MA; Sund NJ; Robin AL Am J Ophthalmol; 2011 Dec; 152(6):982-8. PubMed ID: 21821228 [TBL] [Abstract][Full Text] [Related]
8. Development of an instrument to measure glaucoma medication self-efficacy and outcome expectations. Sleath B; Blalock SJ; Robin A; Hartnett ME; Covert D; DeVellis B; Giangiacomo A Eye (Lond); 2010 Apr; 24(4):624-31. PubMed ID: 19648896 [TBL] [Abstract][Full Text] [Related]
9. Prevalence and correlates of self-reported nonadherence with eye drop treatment: the Belgian Compliance Study in Ophthalmology (BCSO). Vandenbroeck S; De Geest S; Dobbels F; Fieuws S; Stalmans I; Zeyen T J Glaucoma; 2011 Sep; 20(7):414-21. PubMed ID: 21048510 [TBL] [Abstract][Full Text] [Related]
10. Measurement of adherence to brimonidine therapy for glaucoma using electronic monitoring. Hermann MM; Bron AM; Creuzot-Garcher CP; Diestelhorst M J Glaucoma; 2011 Oct; 20(8):502-8. PubMed ID: 20852438 [TBL] [Abstract][Full Text] [Related]
11. The Relationship of Self-Report and Medication Possession With Glaucoma Medication Administration Success. Hein AM; Rosdahl JA; Bosworth HB; Woolson SL; Olsen MK; Kirshner MA; Muir KW J Glaucoma; 2019 Mar; 28(3):e46-e48. PubMed ID: 30822299 [TBL] [Abstract][Full Text] [Related]
12. Electronic monitoring to assess adherence with once-daily glaucoma medications and risk factors for nonadherence: the automated dosing reminder study. Boland MV; Chang DS; Frazier T; Plyler R; Friedman DS JAMA Ophthalmol; 2014 Jul; 132(7):838-44. PubMed ID: 24830878 [TBL] [Abstract][Full Text] [Related]
13. The Most Common Barriers to Glaucoma Medication Adherence: A Cross-Sectional Survey. Newman-Casey PA; Robin AL; Blachley T; Farris K; Heisler M; Resnicow K; Lee PP Ophthalmology; 2015 Jul; 122(7):1308-16. PubMed ID: 25912144 [TBL] [Abstract][Full Text] [Related]
14. Personality traits, depression, and objectively measured adherence to once-daily prostaglandin analog medication in glaucoma. Holló G; Kóthy P; Géczy A; Vargha P J Glaucoma; 2009; 18(4):288-92. PubMed ID: 19365193 [TBL] [Abstract][Full Text] [Related]
15. Glaucoma Patient Preferences for Video Education on Eye Drop Technique. Davis SA; Carpenter DM; Blalock SJ; Budenz DL; Lee C; Muir KW; Robin AL; Sleath B Optom Vis Sci; 2019 May; 96(5):325-330. PubMed ID: 31046014 [TBL] [Abstract][Full Text] [Related]
16. How glaucoma patient characteristics, self-efficacy and patient-provider communication are associated with eye drop technique. Sayner R; Carpenter DM; Robin AL; Blalock SJ; Muir KW; Vitko M; Hartnett ME; Lawrence SD; Giangiacomo AL; Tudor G; Goldsmith JA; Sleath B Int J Pharm Pract; 2016 Apr; 24(2):78-85. PubMed ID: 26303667 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of eye drop administration technique in patients with glaucoma or ocular hypertension. Schwartz GF; Hollander DA; Williams JM Curr Med Res Opin; 2013 Nov; 29(11):1515-22. PubMed ID: 24006861 [TBL] [Abstract][Full Text] [Related]
18. Impact of the Support, Educate, Empower Personalized Glaucoma Coaching Program Pilot Study on Eye Drop Instillation Technique and Self-Efficacy. Schneider KJ; Hollenhorst CN; Valicevic AN; Niziol LM; Heisler M; Musch DC; Cain SM; Newman-Casey PA Ophthalmol Glaucoma; 2021; 4(1):42-50. PubMed ID: 32781286 [TBL] [Abstract][Full Text] [Related]
19. Readability of prescription labels and medication recall in a population of tertiary referral glaucoma patients. O'Hare F; Jeganathan VS; Rokahr CG; Rogers SL; Crowston JG Clin Exp Ophthalmol; 2009 Dec; 37(9):849-54. PubMed ID: 20092593 [TBL] [Abstract][Full Text] [Related]
20. Comparisons of Self-reported Glaucoma Medication Adherence With a New Wireless Device: A Pilot Study. Gatwood JD; Johnson J; Jerkins B J Glaucoma; 2017 Nov; 26(11):1056-1061. PubMed ID: 29099436 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]